Co-Diagnostics Statistics
Share Statistics
Co-Diagnostics has 33.71M
shares outstanding. The number of shares has increased by 2.08%
in one year.
| Shares Outstanding | 33.71M |
| Shares Change (YoY) | 2.08% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | 18.76% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 5,566 |
| FTD / Avg. Volume | 2.34% |
Short Selling Information
The latest short interest is 139.01K, so 0.41% of the outstanding
shares have been sold short.
| Short Interest | 139.01K |
| Short % of Shares Out | 0.41% |
| Short % of Float | 0.45% |
| Short Ratio (days to cover) | 1.42 |
Valuation Ratios
The PE ratio is -0.6 and the forward
PE ratio is 3.81.
Co-Diagnostics's PEG ratio is
-0.18.
| PE Ratio | -0.6 |
| Forward PE | 3.81 |
| PS Ratio | 5.81 |
| Forward PS | 13.1 |
| PB Ratio | 0.42 |
| P/FCF Ratio | -0.76 |
| PEG Ratio | -0.18 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Co-Diagnostics.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.41,
with a Debt / Equity ratio of 0.04.
| Current Ratio | 4.41 |
| Quick Ratio | 4.27 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | -0.06 |
| Debt / FCF | -0.07 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $29,660.3 |
| Profits Per Employee | $-285,144 |
| Employee Count | 132 |
| Asset Turnover | 0.06 |
| Inventory Turnover | 0.93 |
Taxes
| Income Tax | 57.37K |
| Effective Tax Rate | -0.15% |
Stock Price Statistics
The stock price has increased by -69.64% in the
last 52 weeks. The beta is 0.84, so Co-Diagnostics's
price volatility has been higher than the market average.
| Beta | 0.84 |
| 52-Week Price Change | -69.64% |
| 50-Day Moving Average | 0.39 |
| 200-Day Moving Average | 0.87 |
| Relative Strength Index (RSI) | 44.08 |
| Average Volume (20 Days) | 238,218 |
Income Statement
In the last 12 months, Co-Diagnostics had revenue of 3.92M
and earned -37.64M
in profits. Earnings per share was -1.24.
| Revenue | 3.92M |
| Gross Profit | 2.92M |
| Operating Income | -40.08M |
| Net Income | -37.64M |
| EBITDA | -38.7M |
| EBIT | -40.08M |
| Earnings Per Share (EPS) | -1.24 |
Full Income StatementBalance Sheet
The company has 2.94M in cash and 2.15M in
debt, giving a net cash position of 784.37K.
| Cash & Cash Equivalents | 2.94M |
| Total Debt | 2.15M |
| Net Cash | 784.37K |
| Retained Earnings | -33.04M |
| Total Assets | 64M |
| Working Capital | 24.98M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -29.16M
and capital expenditures -748.35K, giving a free cash flow of -29.9M.
| Operating Cash Flow | -29.16M |
| Capital Expenditures | -748.35K |
| Free Cash Flow | -29.9M |
| FCF Per Share | -0.99 |
Full Cash Flow StatementMargins
Gross margin is 74.48%, with operating and profit margins of -1023.75% and -961.37%.
| Gross Margin | 74.48% |
| Operating Margin | -1023.75% |
| Pretax Margin | -959.9% |
| Profit Margin | -961.37% |
| EBITDA Margin | -988.57% |
| EBIT Margin | -1023.75% |
| FCF Margin | -763.78% |
